Suggested Topics within your search.
Showing 1 - 20 results of 120 for search '"Programmed Cell Death-ligand 1"', query time: 4.48s Refine Results
  1. 1
    PD-L1 and CD8-Tumor-Infiltrating Lymphocytes Expression in Laryngeal Squamous Cell Carcinoma
    Subjects: “...programmed cell death ligand-1...”
    Get full text
    Article
  2. 2
    Successful Treatment of Pulmonary Pleomorphic Carcinoma with Nivolumab: A Case Report
    Subjects: “...Programmed cell death ligand-1...”
    Get full text
    Article
  3. 3
    Interobserver Reproducibility of PD-L1 Biomarker in Non-small Cell Lung Cancer: A Multi-Institutional Study by 27 Pathologists
    Subjects: “...programmed cell death-ligand 1...”
    Get full text
    Article
  4. 4
    PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28–8 and E1L3N)
    Subjects: “...Programmed cell death ligand 1...”
    Get full text
    Article
  5. 5
    Brain Metastases Status and Immunotherapy Efficacy in Advanced Lung Cancer: A Systematic Review and Meta-Analysis
    Subjects: “...programmed cell death ligand 1...”
    Get full text
    Article
  6. 6
    The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes
    Subjects: “...soluble programmed cell death-ligand 1...”
    Get full text
    Article
  7. 7
    Clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis
    by Ding X, Chen Q, Yang Z, Li J, Zhan H, Lu N, Chen M, Yang Y, Wang J, Yang D
    Published 2019-05-01
    Subjects: “...programmed cell death ligand 1...”
    Get full text
    Article
  8. 8
    Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis
    Subjects: “...programmed cell death ligand-1...”
    Get full text
    Article
  9. 9
    CD45RO+ Memory T Lymphocytes As A Candidate Marker for Non–small Cell Lung Cancer
    Subjects: “...programmed cell death ligand 1...”
    Get full text
    Article
  10. 10
    Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer
    by Zhang Q, Zong L, Zhang H, Xie W, Yang F, Sun W, Cui B, Zhang Y
    Published 2021-07-01
    Subjects: “...programmed cell-death ligand 1...”
    Get full text
    Article
  11. 11
    Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors: A Multi-Institutional Retrospective Study
    Subjects: “...programmed cell death-ligand 1...”
    Get full text
    Article
  12. 12
    CD44, a marker of cancer stem cells, is positively correlated with PD-L1 expression and immune cells infiltration in lung adenocarcinoma
    Subjects: “...Programmed cell death ligand-1...”
    Get full text
    Article
  13. 13
    Role of GLUT-1 in the Upregulation of PD-L1 Expression After Radiotherapy and Association of PD-L1 with Favourable Overall Survival in Hypopharyngeal Cancer
    by Shen LF, Zhou SH, Guo Y
    Published 2020-11-01
    Subjects: “...programmed cell death ligand 1...”
    Get full text
    Article
  14. 14
    Elevated serum soluble programmed cell death ligand 1 concentration as a potential marker for poor prognosis in small cell lung cancer patients with chemotherapy
    Subjects: “...Programmed cell death ligand 1...”
    Get full text
    Article
  15. 15
    The Clinical Significance of Soluble Programmed Cell Death-Ligand 1 (sPD-L1) in Patients With Gliomas
    Subjects: “...soluble programmed cell death-ligand 1...”
    Get full text
    Article
  16. 16
    Efficacy of immune checkpoint inhibitors according to PD‐L1 tumor proportion scores in non‐small cell lung cancer
    Subjects: “...programmed cell death ligand 1...”
    Get full text
    Article
  17. 17
    Epithelial-to-mesenchymal transition and its association with PD-L1 and CD8 in thyroid cancer
    Subjects: “...programmed cell death-ligand 1...”
    Get full text
    Article
  18. 18
    Analysis of the Correlation between Molecular Structural Differences of PD-1/PD-L1 Inhibitors and Adverse Events
    by Tongji XIE, Shouzheng WANG, Puyuan XING
    Published 2020-07-01
    Subjects: “...programmed cell death ligand 1...”
    Get full text
    Article
  19. 19
    Present and Future of Efficacy Biomarkers in Immune Checkpoint Inhibitors 
of Small Cell Lung Cancer
    by Yaning YANG, Yan WANG
    Published 2020-10-01
    Subjects: “...programmed cell death-ligand 1...”
    Get full text
    Article
  20. 20
    Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice
    by Tong Li, Jiandong Wang
    Published 2020-07-01
    Subjects: “...Programmed cell death-ligand 1...”
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search